Upcoming Events | Past Events | Subscribe (RSS)
The CSIS Global Health Policy Center holds a number of events every year. In addition to our High Level Speaker Series and our Fault Lines in Global Health debates
, we host events with experts from around the world on important current issues in global health. Many of these events will be webcast live, giving you the opportunity to participate from any location and even ask questions of our speakers and panelists beforehand. Your engagement is vital to the continuation of the Global Health Policy Center's work.
If you haven't already, sign up for email updates
to make sure you are aware of all upcoming events, news and publications.
As countries around the world work toward universal health coverage, leaders are looking for ways to best use resources to improve health and promote long-term economic development and social stability.
As the Ebola epidemic continues in West Africa, a major challenge impeding international efforts to “get to zero” Ebola cases and deaths is the absence of effective, portable, and affordable Ebola diagnostic tools. There has been a considerable push by industry, governments, NGOs, international organizations, and foundations to develop these new tests. While there are many promising tools on the horizon, there are still a number of challenges and unknowns that need to be considered in terms of research and development, and implementation.
Please join us on Friday, February 13 for a lively conversation with Tolbert Nyenswah, Assistant Minister of Health and Head of Liberia's Incident Management System (IMS). The discussion will focus on his role leading Liberia's Ebola response during this fall’s crisis period, the priority challenges during this current phase, and prospects for renewal of the health sector. J. Stephen Morrison, Senior Vice President and Director of the CSIS Global Health Policy Center will moderate.
On Friday, February 6, please join two senior Obama administration officials, Mr. Michael Botticelli, Acting Director of the White House Office of National Drug Control Policy and Ambassador William Brownfield, Assistant Secretary of State for International Narcotics and Law Enforcement Affairs, for a timely -- and lively -- discussion of U.S. policy approaches to drug policy at home and abroad. J. Stephen Morrison, Senior VP and Director of the CSIS Global Health Policy Center, will moderate.
Please join us on Thursday, February 6, for a lively conversation with Mr. Anthony Banbury on the creation of UNMEER, its progress, and outstanding challenges. Mr. Banbury will also discuss how lessons learned from his previous experiences with the Haiti Earthquake, the conflict in the Central African Republic, and the elimination of chemical weapons in Syria apply to the current Ebola crisis and UNMEER. J. Stephen Morrison, Senior Vice-President and Director of the CSIS Global Health Policy Center, will moderate.
Please join us on World Cancer Day for a round table discussion of prospects for research, development, and delivery of tools that can be used effectively and affordably to prevent and treat cancer in low and middle income countries.Confirmed participants include Dr. Harold Varmus, Director of the National Concert Institute; Ambassador Sally Cowal, Senior Vice President of Global Health at the American Cancer Society; and Mr. Thomas Bollyky, Senior Fellow for Global Health, Economics, and Development at The Council on Foreign Relations. Dr. J. Stephen Morrison, Senior Vice President and Director of the CSIS Global Health Policy Center, will moderate.
There are rapidly accelerating efforts underway by industry, governments, NGOS, international organizations, and foundations to bring forward Ebola vaccines and antivirals. There have been promising early returns, amidst considerable unknowns and acute pressures to find safe, effective, and affordable new technological tools. Ambitious field trials are set to begin in the new year in West Africa. Hear what lies ahead from those on the front lines:
Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease (NIAID)
Dr. Moncef Slaoui, Member of the GSK Board of Directors and the Corporate Executive Team
Dr. Johan Van Hoof, Global Therapeutic Area Head, Infectious Diseases & Vaccines, Janssen Research & Development, LLC
Mr. Rohit Malpani, Director of Policy and Analysis, Medecins Sans Frontieres Access Campaign
Dr. Julie Gerberding, President, Merck Vaccines
Dr. J. Stephen Morrison, Senior Vice President and Director of the CSIS Global Health Policy Center will moderate the panel.
On December 8, the CSIS Global Health Policy Center will host a major day-long conference on the future of global malaria efforts. It will open with a high-level deliberation over the strategic long-term goal of elimination, highlighting the political, financial, and institutional requisites. It will feature expert roundtables on drug and insecticide resistance, future technologies (vaccines, therapies, diagnostics), and financing. There will be a special focus on civilian-military cooperation in the Mekong Subregion. On that day, CSIS will release five commissioned policy analyses.
As the world is struggling to tackle the Ebola crisis in West Africa, it is becoming increasingly important to understand how Ebola is affecting the economy in the region. Mitigating the economic impacts of Ebola will be crucial for post-disease reconstruction. Please join us for a panel discussion on this topic featuring David Evans, Senior Economist at the World Bank Africa Region, Abebe Aemro Selassie, Deputy Director of the International Monetary Fund African Department, and Phillip van Niekerk, Managing Partner at Calabar Consulting. J. Stephen Morrison, Director of the CSIS Global Health Policy Center, will moderate the panel.
Biomedical research towards the prevention and treatment of HIV, tuberculosis, malaria, and other major global health challenges remains our long-term hope for bringing these epidemics to an end. Understanding when new technologies are likely to emerge from the research and development pipeline, and how they might impact ongoing efforts, is vital to ensuring their rapid uptake and integration.
Myanmar is in the third year of a historic transition. There is active debate in Washington whether the reforms have regressed, stalled, or progressed. Between August 17 and 22, 2014, the Center for Strategic and International Studies (CSIS) organized a delegation to examine the status of the Myanmar transition in three key dimensions: health and development; political reform and governance; and conflict resolution with the country’s minority groups. On October 22 from 3:00PM to 5:00PM we will gather at CSIS for the release of the delegation's report, Myanmar: Regressed, Stalled, or Moving Forward? The session will feature reflections by delegation members, a keynote from a senior administration official, and panel discussions on electoral preparations and critical health challenges.
See All Past Events »